Am. J. Respir. Crit. Care Med., Volume 157, Number 5, May 1998, 1423-1428

Pulmonary Artery Remodeling Differs in Hypoxia- and Monocrotaline-induced Pulmonary Hypertension

ROBERT J. van SUYLEN, JOS F. M. SMITS, and MAT J. A. P. DAEMEN

Departments of Pathology and Pharmacology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands

In the present study we analyzed structural characteristics of muscular pulmonary arteries and arterioles in two classic models of pulmonary hypertension, the rat hypoxia and monocrotaline models. We hypothesized that an increase in medial cross-sectional area would result in reduction of the lumen area and that these parameters would correlate with the increase in pulmonary artery pressure (PAP). Four weeks after a single injection of monocrotaline (MCT) or after 4 wk of hypoxic exposure the rats were killed. Both MCT and chronic hypoxia induced right ventricular hypertrophy. In separate groups of rats both MCT and chronic hypoxia increased PAP. MCT increased the media cross-sectional area of pulmonary arteries with an external diameter between 30-100 µm and 101-200 µm and reduced the lumen area of pulmonary arteries with an external diameter between 101-200 µm. Chronic hypoxia only slightly increased the media cross-sectional area without a change of the lumen area. Both MCT and hypoxia increased the percentage of partly muscularized and muscularized arterioles. The angiotensin-converting enzyme (ACE) inhibitor captopril (0.5 mg/kg/h) had no effect on MCT-induced pulmonary hypertension, right ventricular hypertrophy, and pulmonary artery remodeling. In chronic hypoxic rats it prevented an increase in medial cross-sectional area of pulmonary arteries with an external diameter between 30-100 µm and attenuated the increase in the percentage of muscularized arterioles, without any effect on the PAP. We conclude that MCT, in contrast to chronic hypoxia, induces structural changes of muscular pulmonary arteries with an external diameter between 101-200 µm which may contribute to an increased PAP and right ventricular hypertrophy. These data also suggest that angiotensin II plays a pivotal role in remodeling of pulmonary arteries in hypoxia but not in MCT-induced pulmonary hypertension. van Suylen RJ, Smits JFM, Daemen MJAP. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.

This article has been cited by other articles:

				J. Boissiere, M. Gautier, M.-C. Machet, G. Hanton, P. Bonnet, and V. Eder Doppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunction Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2450 - H2455. [Abstract] [Full Text] [PDF]

				E. Villamor, C. G. A. Kessels, K. Ruijtenbeek, R. J. van Suylen, J. Belik, J. G. R. De Mey, and C. E. Blanco Chronic in ovo hypoxia decreases pulmonary arterial contractile reactivity and induces biventricular cardiac enlargement in the chicken embryo Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R642 - R651. [Abstract] [Full Text] [PDF]

				T. Nishimura, J. L. Faul, G. J. Berry, L. T. Vaszar, D. Qiu, R. G. Pearl, and P. N. Kao Simvastatin Attenuates Smooth Muscle Neointimal Proliferation and Pulmonary Hypertension in Rats Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1403 - 1408. [Abstract] [Full Text] [PDF]

				A. A. Aldashev, A. S. Sarybaev, A. S. Sydykov, B. B. Kalmyrzaev, E. V. Kim, L. B. Mamanova, R. Maripov, B. K. Kojonazarov, M. M. Mirrakhimov, M. R. Wilkins, et al. Characterization of High-Altitude Pulmonary Hypertension in the Kyrgyz: Association with Angiotensin-Converting Enzyme Genotype Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1396 - 1402. [Abstract] [Full Text] [PDF]

				R. J. van SUYLEN, W. M. AARTSEN, J. F. M. SMITS, and M. J. A. P. DAEMEN Dissociation of Pulmonary Vascular Remodeling and Right Ventricular Pressure in Tissue Angiotensin-converting Enzyme-deficient Mice Under Conditions of Chronic Alveolar Hypoxia Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1241 - 1245. [Abstract] [Full Text]

				T. NISHIMURA, J. L. FAUL, G. J. BERRY, I. VEVE, R. G. PEARL, and P. N. KAO 40-O-(2-Hydroxyethyl)-rapamycin Attenuates Pulmonary Arterial Hypertension and Neointimal Formation in Rats Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 498 - 502. [Abstract] [Full Text]

				K. M. Ito, M. Sato, K. Ushijima, M. Nakai, and K. Ito Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1786 - H1795. [Abstract] [Full Text] [PDF]

				F. QING, T. J. McCARTHY, J. MARKHAM, and D. P. SCHUSTER Pulmonary Angiotensin-converting Enzyme (ACE) Binding and Inhibition in Humans . A Positron Emission Tomography Study Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2019 - 2025. [Abstract] [Full Text]

				C. Chassagne, S. Eddahibi, C. Adamy, D. Rideau, F. Marotte, J.-L. Dubois-Randé, S. Adnot, J.-L. Samuel, and E. Teiger Modulation of Angiotensin II Receptor Expression during Development and Regression of Hypoxic Pulmonary Hypertension Am. J. Respir. Cell Mol. Biol., March 1, 2000; 22(3): 323 - 332. [Abstract] [Full Text]

				N. W. Morrell, P. D. Upton, S. Kotecha, A. Huntley, M. H. Yacoub, J. M. Polak, and J. Wharton Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L440 - L448. [Abstract] [Full Text] [PDF]

				R. J. van SUYLEN, E. F. WOUTERS, H. J. PENNINGS, E. C. CHERIEX, P. E. van POL, A. W. AMBERGEN, A.-M. VERMELIS, and M. J. DAEMEN The DD Genotype of the Angiotensin Converting Enzyme Gene Is Negatively Associated with Right Ventricular Hypertrophy In Male Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1791 - 1795. [Abstract] [Full Text]